Overview of the Approval Process for NMPA Registration of Class I Medical Devices
分类:行业新闻 发布时间:2024-10-30 16:23:18
Engaging a local regulatory consultant can also help streamline the process and ensure compliance with all local regulations.

The approval process for NMPA registration of Class I medical devices in China is generally simpler than for Class II and III devices, as Class I devices are considered low-risk. Here’s an overview of the process:

1. Determine Classification

  • Confirm that the device qualifies as a Class I medical device according to the NMPA classification guidelines.

2. Prepare Required Documentation

  • Although Class I devices do not require a formal approval process, manufacturers must prepare the following documents for record-filing:
    • Application Form: Basic information about the device and manufacturer.
    • Device Description: Technical specifications, intended use, and any relevant standards.
    • Quality Management System Documentation: Evidence of compliance with ISO 13485 or equivalent, demonstrating a robust quality management system.

3. Local Agent Requirement

  • Foreign manufacturers must appoint a local agent in China to assist with the registration process and communicate with the NMPA.

4. Filing the Record

  • Submit the required documents through the NMPA’s online system. Ensure that all documents are in Chinese and follow the specific formatting guidelines provided by the NMPA.

5. Review Process

  • The NMPA conducts a review of the submitted documents. This review focuses on ensuring that the device meets the relevant safety and efficacy standards.
  • The review period for Class I devices is typically shorter than that for Class II or III devices, often taking around 20 working days.

6. Issuance of Record-Filing Certificate

  • If the submission meets all requirements, the NMPA issues a record-filing certificate. This certificate allows the manufacturer to market the Class I medical device in China.

7. Post-Market Obligations

  • Once registered, manufacturers must comply with post-market surveillance requirements, including:
    • Reporting adverse events.
    • Maintaining product quality and safety.
    • Conducting regular updates of product information as necessary.

Additional Considerations

  • Labeling and Instructions for Use: Ensure that product labeling and instructions comply with NMPA requirements, including translation into Chinese.
  • Product Quality: Manufacturers should establish and maintain a quality management system to ensure ongoing compliance and safety.

Useful Resources

  • For detailed information, manufacturers can refer to the official NMPA website, which provides guidance on registration and requirements for medical devices.

Engaging a local regulatory consultant can also help streamline the process and ensure compliance with all local regulations.

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn

1(1).jpg